MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to ...
BackgroundHearing loss is among the most prevalent and potentially modifiable risk factors for dementia across the life ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results